Background: To determine whether magnetic resonance imaging (MRI) and apparent diffusion coefficient (ADC) are able to distinguish between adenocarcinoma originating from the uterine cervix and endometrium.

Methods: Institutional review board approval and informed consent were obtained. From May 2006 to June 2008, 29 women 25-73 years old (mean age, 50.3 years) with a cervical biopsy yielding adenocarcinoma were enrolled for 3-T MR study with the imaging pulse-sequence protocol of T2-weighted imaging (T2WI) and dynamic contrast-enhanced (DCE) MRI and diffusion-weighted MRI (DWI, b = 0, 1000 sec/mm2). The extent and shapes of the tumor and ADC values were evaluated by two radiologists retrospectively. Surgical histopathology served as the reference standard of the tumor origin from the cervix (n = 22) or endometrium (n = 7). The Mann-Whitney U test was used for statistical comparison and receiver operating characteristic (ROC) analysis was used to obtain optimal ADC cut off values.

Results: A longitudinal shape occurred significantly more frequently in endometrial cancer, and an oval shape was more frequently found in cervical cancer (p = 0.011). Mean ADC values were significantly lower in endometrial cancer (76.6 × 10(-5) mm2/sec) than in cervical cancer (96.9 × 10(-5) mm2/sec). Receiver operating characteristic analysis yielded an optimal ADC cutoff value of 70 × 10(-5) mm2/sec to distinguish cervical cancer from endometrial cancer.

Conclusion: MRI may distinguish between most uterine adenocarcinoma originating from the cervix and endometrium using distinctive characteristics found on T2WI and DCE. When tumors show an ambiguous morphology, the ADC value of the tumor may be helpful for further differentiation.

Download full-text PDF

Source

Publication Analysis

Top Keywords

cervix endometrium
12
cervical cancer
12
10-5 mm2/sec
12
magnetic resonance
8
resonance imaging
8
apparent diffusion
8
diffusion coefficient
8
uterine cervix
8
adenocarcinoma originating
8
adc values
8

Similar Publications

Ovarian cancer has a poor prognosis, and screening methods have not been established. Biomarkers based on molecular genetic characteristics must be identified to develop diagnostic and therapeutic strategies for all cancer types, particularly ovarian cancer. The present study aimed to evaluate the usefulness of genetic analysis of cervical and endometrial liquid-based cytology (LBC) specimens for detecting somatic mutations in patients with ovarian cancer.

View Article and Find Full Text PDF

The role of genetics in susceptibility to radiotherapy-induced toxicities is unclear. A strong impact of genetics should cause correlated toxicities in patients with metachronous double radiotherapy. We ascertained information about demographics, lifestyle, radiotherapy and early toxicities in irradiated tissues for a retrospective cohort of 98 patients from 2 hospitals who underwent two metachronous radiotherapeutic treatments (2007-2022) of different anatomical regions.

View Article and Find Full Text PDF

Background: A didelphic uterus represents a unique and infrequent congenital condition in which a woman possesses two distinct uteri, each with its own cervix. This anomaly arises due to partial or incomplete merging of the Müllerian ducts during the developmental stages in the womb. Accounting for uterine malformations, a didelphic uterus is a relatively rare condition, affecting approximately 0.

View Article and Find Full Text PDF

Background: Recurrent gynecological clear cell carcinoma (rGCCC) has a low objective response rate (ORR) to chemotherapy. Previous preclinical and clinical data suggest a potential synergy between immune checkpoint inhibitors and bevacizumab in rGCCC. Dostarlimab, a humanized monoclonal antibody targeting programmed cell death protein 1 (PD-1), combined with the anti-angiogenic bevacizumab, presents a novel therapeutic approach.

View Article and Find Full Text PDF

Primary hepatoid adenocarcinoma (HAC) of the uterus is a particular tumour that bears high similarity to hepatocellular carcinoma histologically, and may easily be misdiagnosed because it is rare if you don' t remember it. In this report, we describe two cases of alpha-fetoprotein (AFP)-producing HAC of the uterus. Case 1 was a 69-year-old postmenopausal woman who was presented to the hospital for a medical examination.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!